Recent efforts have led to the identification of several markers, such as CD25 and CD44, most of which are significantly expressed in CML LSCs but are also detectable in healthy hematopoietic stem and progenitor cells (HSPCs) [27,28,29] (Table 1). The gene discussed is IL2RA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.